Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
March 30, 2021

Coronavirus company news summary – J&J to deliver 220m doses of single-shot Covid-19 vaccine to African Union member states – GSK agrees to produce Novavax vaccine in the UK

By Chris Lo

Johnson & Johnson subsidiary Janssen Pharmaceutica has signed an advance purchase agreement with the African Vaccine Acquisition Trust (AVAT) to manufacture and deliver up to 220 million doses of its single-shot Covid-19 vaccine. The vaccines will be supplied to the African Union’s 55 member states by Q3 2021. Under the agreement, AVAT has an option to order an additional 180 million doses, for a total of up to 400 million doses by 2022.

British pharmaceutical giant GSK has signed an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to 60 million doses of Novavax’s coronavirus vaccine, NVX-CoV2373, for use in the UK. GSK will provide its fill-finish site in Barnard Castle for the production of the vaccine. The UK government ordered the 60 million doses from Novavax under an advance purchase contract.

Russian Direct Investment Fund and Chinese biotech company Shenzhen Yuanxing Gene-tech have agreed to produce over 60 million doses of the Sputnik V Covid-19 vaccine in China, enough to vaccinate 30 million individuals. Commercial production of the vaccines is expected to begin in May 2021.

Related Companies

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU